Skip to main content
Premium Trial:

Request an Annual Quote

IBM, Molecular Mining Sign Marketing and Research Agreement

NEW YORK, June 10-IBM and Molecular Mining Corporation will work together to develop data mining and software products that analyze gene and protein expression, predict individual drug responses, and probe the genetic causes of disease, the companies said today.

 

The companies will launch a joint sales and marketing effort that pairs IBM DiscoveryLink software with MMC's GeneLinker visualization and analysis systems. GeneLinker platinum will be shipped on IBM Intellistation systems, and new MMC products will be available first through IBM platforms.

 

Both companies will become "preferred partners" for one another.

 

MMC will use IBM systems for internal development, including an infrastructure cluster of Linux-based eServer xSeries systems supported by the IBM Life Sciences Framework.

 

IBM and MMC may also collaborate to find new methods of pattern discovery and gene expression analysis.

 

Financial details were not disclosed.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.